Sign in: Staff/Students
The University of Liverpool and Scott Bader Company Ltd have formed a joint venture; Polymer Mimetics, to develop a novel polymer chemistry platform.
With a funding commitment of more than £1million, Polymer Mimetics will build on technology developed by Professor Steve Rannard, from the University’s Department of Chemistry.
The technology takes widely-available chemical building blocks and, in a facile, highly scalable process, transforms them into high performance polymeric products with the potential to engineer in degradability. It is envisaged that this new generation of materials will have broad applicability in several markets including coatings, composites and speciality additives.
The joint venture with the University of Liverpool demonstrates Scott Bader’s commitment to work with technology leaders to develop sustainable new technologies, and will be based in Liverpool.
Kevin Matthews, Group Chief Executive of Scott Bader, said: “We are delighted to partner with the University of Liverpool to launch Polymer Mimetics and we look forward to developing innovative products and effective sustainable solutions for our customers.”
Professor Steve Rannard said: “Polymer Mimetics is a genuine industry-academia translation of new chemical technologies into a vehicle that will allow economic impact and we are highly grateful to Scott Bader for their faith in our chemistry and the vision to invest early in its development.”
Professor Anthony Hollander, Pro-Vice-Chancellor for Research & Impact at the University of Liverpool, said: “This technology was initially developed via funding from the Engineering and Physical Sciences Research Council (EPSRC) and has received significant support from the University’s IP Commercialisation Team2 over the last 4 years.
“We’re pleased to see these efforts come to fruition via this exciting partnership with Scott Bader, and we’re especially pleased to secure inward investment and the creation of new jobs in the Liverpool City Region.”
The founding Research Group was Professor Steve Rannard, Dr Pierre Chambon and Savannah Cassin, who work at the University of Liverpool’s Department of Chemistry. Professor Rannard is also theme lead for Nanomedicine at the University’s Materials Innovation Factory.
The University’s IP Commercialisation Team works with academics to bring University technologies to market. The team provides practical advice and support for filing patent applications to protect University inventions, negotiating commercial licences working with industry partners, and setting up spin-out companies.
All recent news
Heseltine Institute report for LCR APPG leads calls for Westminster to deliver “clean, green and inclusive growth”
Using Liverpool’s e-scooters safely
Llama antibodies have “significant potential” as potent COVID-19 treatment
COVID-19 hospital mortality rates not reducing in patients with history of cancer, study finds
Follow us on social media
Liverpool is leading a new global network to bring together animal & human #coronavirus research communities.
Funded by @UKRI partners include @APHAgovuk @roslininstitute @Pirbright_Inst @Cambridge_Uni
#OneHealth #LivUniCovid @ThePandemicInst @livuniHLS https://bit.ly/3AEEqHr
Preventing the next global pandemics depends on the collective capacity of universities. For @Wonkhe this morning I’ve written about Liverpool, Covid-19 and @ThePandemicInst, and what next: https://wonkhe.com/blogs/if-pandemics-are-predictable-could-they-be-preventable/
Researchers from @livuniHLS have contributed to new research showing that llama antibodies have 'significant potential' as a #COVID19 treatment.
Published in @NatureComms today, the study was led by @RosFrankInst.
#LivUniCovid | @molvirol | @LivUni_IVES